Trends in Use of High-Cost Antihyperglycemic Drugs Among US Adults with Type 2 Diabetes.

ABSTRACT:

Background

Some antihyperglycemic drugs can reduce cardiovascular events, slow the progression of kidney disease, and prevent death, but they are more expensive than older drugs.

Objectives

(1) To estimate trends in use of antihyperglycemic drugs by cost; (2) to examine use of high-cost drugs by race/ethnicity, income, and insurance status DESIGN: Cross-sectional analysis of the 2003-2018 National Health and Nutrition Examination Survey PARTICIPANTS: US adults ≥18 years with type 2 diabetes EXPOSURES: Race/ethnicity, income, and insurance status MAIN MEASURES: Low-cost noninsulin medications included any drugs that had at least one generic version approved by the Food and Drug Administration. Human regular, NPH, and premixed NPH/regular 70/30 insulins were classified as low-

SUBMITTER: Le P 

PROVIDER: S-EPMC9849515 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature